183 related articles for article (PubMed ID: 8763992)
1. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals.
Yao QY; Tierney RJ; Croom-Carter D; Cooper GM; Ellis CJ; Rowe M; Rickinson AB
J Virol; 1996 Aug; 70(8):4895-903. PubMed ID: 8763992
[TBL] [Abstract][Full Text] [Related]
2. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.
Yao QY; Tierney RJ; Croom-Carter D; Dukers D; Cooper GM; Ellis CJ; Rowe M; Rickinson AB
J Virol; 1996 Aug; 70(8):4884-94. PubMed ID: 8763991
[TBL] [Abstract][Full Text] [Related]
3. Identification of two types of naturally-occurring intertypic recombinants of Epstein-Barr virus.
Kim SM; Kang SH; Lee WK
Mol Cells; 2006 Apr; 21(2):302-7. PubMed ID: 16682827
[TBL] [Abstract][Full Text] [Related]
4. Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2.
Aguirre AJ; Robertson ES
Virology; 1999 Nov; 264(2):359-69. PubMed ID: 10562498
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family.
Sawada A; Croom-Carter D; Kondo O; Yasui M; Koyama-Sato M; Inoue M; Kawa K; Rickinson AB; Tierney RJ
J Gen Virol; 2011 May; 92(Pt 5):1032-1043. PubMed ID: 21248177
[TBL] [Abstract][Full Text] [Related]
6. Novel intertypic recombinants of epstein-barr virus in the chinese population.
Midgley RS; Blake NW; Yao QY; Croom-Carter D; Cheung ST; Leung SF; Chan AT; Johnson PJ; Huang D; Rickinson AB; Lee SP
J Virol; 2000 Feb; 74(3):1544-8. PubMed ID: 10627567
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes.
Görzer I; Niesters HG; Cornelissen JJ; Puchhammer-Stöckl E
Virus Res; 2006 Jun; 118(1-2):105-14. PubMed ID: 16406167
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
Aguirre AJ; Robertson ES
J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia.
Walling DM; Raab-Traub N
J Virol; 1994 Dec; 68(12):7909-17. PubMed ID: 7966581
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.
Kaymaz Y; Oduor CI; Aydemir O; Luftig MA; Otieno JA; Ong'echa JM; Bailey JA; Moormann AM
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581102
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus recombinants from overlapping cosmid fragments.
Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort.
Yao QY; Croom-Carter DS; Tierney RJ; Habeshaw G; Wilde JT; Hill FG; Conlon C; Rickinson AB
J Virol; 1998 May; 72(5):4352-63. PubMed ID: 9557725
[TBL] [Abstract][Full Text] [Related]
15. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
Schlager S; Speck SH; Woisetschläger M
J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
[TBL] [Abstract][Full Text] [Related]
16. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers.
Yao QY; Rowe M; Martin B; Young LS; Rickinson AB
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1579-90. PubMed ID: 1649896
[TBL] [Abstract][Full Text] [Related]
17. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
[TBL] [Abstract][Full Text] [Related]
18. Sequence variation of EBNA2 of Epstein-Barr virus isolates from Korea.
Shim YS; Kim CW; Lee WK
Mol Cells; 1998 Apr; 8(2):226-32. PubMed ID: 9638656
[TBL] [Abstract][Full Text] [Related]
19. Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease.
Schuster V; Seidenspinner S; Kreth HW
J Med Virol; 1996 Jan; 48(1):114-20. PubMed ID: 8825720
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains.
Brooks JM; Croom-Carter DS; Leese AM; Tierney RJ; Habeshaw G; Rickinson AB
J Virol; 2000 Feb; 74(4):1801-9. PubMed ID: 10644353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
